Caxton »

X4 Pharmaceuticals shares owned by Caxton

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Caxton from 13F filings

Historical chart of Caxton investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Caxton

Quarter filed Position value Share count Share price at filing
2025-12-31 $62k 16k 4.00

More positions owned by Caxton

Spdr Gold Tr Gold Shs (GLD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spyre Therapeutics Com New (SYRE)
Mind Medicine Mindmed Com New (MNMD)
Kyverna Therapeutics (KYTX)
Compass Therapeutics (CMPX)
Lexeo Therapeutics (LXEO)
X4 Pharmaceuticals Com New (XFOR)
Inhibikase Therapeutics Com New (IKT)
Sab Biotherapeutics Com New (SABS)
Context Therapeutics (CNTX)

View all positions for Caxton

Top funds holding X4 Pharmaceuticals

Vanguard Group
Braidwell
Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Geode Capital Management
Kingdon Capital Management
Goldman Sachs Group
Stonepine Capital Management
Stempoint Capital
Boothbay Fund Management
State Street Corporation
Pale Fire Capital SE

View all funds holding X4 Pharmaceuticals